Fully autonomous screening for diabetic retinopathy is coming to pharmacies and other locations through a strategic ...

Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...

The Sultanate of Oman is the third country worldwide to implement this project, confirming its commitment to technological ...

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, ...

Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second ...

Gov. Andy Beshear and the Education and Labor Cabinet’s Division of Blind Services encourage Kentuckians to prioritize their ...

KOD's Q2 loss widens as it ramps up clinical studies for three key eye disease treatments with pivotal data readouts planned.

For the first time in Ghana’s history, the country officially joins the global eye care community in commemorating World ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Empowering choice in the pharmacological management of type 2 diabetes One in nine people worldwide lives with diabetes, with 90% affected by type 2 diabetes.1 Despite ongoing advances in therapy and ...

AI healthcare solutions are transforming digital health trends by making patient care more personalized, improving diagnostics, and increasing healthcare efficiency. In this context, we will explore ...